HHS Awards $25M To Walgreens For Decentralized COVID-19 Vaccine Trial

HHS is granting $25 million to Walgreens for a decentralized clinical trial to evaluate COVID-19 vaccine effectiveness, with the goal of enhancing participation across diverse age groups and ethnic backgrounds while gathering real-world data that can be used to conduct future clinical studies. HHS’ Administration for Strategic Preparedness and Response said in a statement Tuesday (July 23) that it is the first time the agency is partnering with a major retail pharmacy on a decentralized clinical trial approach aiming to...